High-Blood Pressure Medication Recalled


RxRecall / Maher Law Firm

RxRecall / Maher Law Firm

Isradipine Recalled

Dow Jones Newswires (2/25, Loftus, Subscription Publication) reported that on Friday, GlaxoSmithKline PLC voluntarily recalled more than 394,200 bottles of isradipine because of a potential tablet mix up at Novartis AG.   U.K.-based Glaxo said Friday “it issued the voluntary recall of all bottles of [DynaCirc] remaining in the U.S. market from wholesalers, pharmacies and hospitals.  GSK spokesman Kevin Colgan said that “because of the recall, the medication will not be available to patients.”

Latest Recall News With RxRecall

Bookmark and Share

Comments are closed.